In A/B testing, follow appropriate A/B testing procedures: Pick a sample size prior to the experiment that gives you appropriate power, or use Armitage's rule for optimal test termination. (Email me if you're interested, I'm happy to send over papers/scan relevant pages from his book). However , it's probably best to use a fixed sample size, as that is what most real life A/B test practitioners use. Picking the sample size can be a bit tricky, but as a rule of thumb, pick something that is large in enough to dectect differences in treatments as small as 1%age point.
In the treatment group B, use the UCB1 procedure. Subject the users to whichever design UCB1 picks, and continue with the learning.
Do not share any information between treatment groups A and B.
Run these tests for a sufficient amount of time over a largish number of clients, and then use permutation tests to determine which treatment, UCB1 vs Neyman-Pearson, performs better.
In all the simulations I've seen, UCB performs simple A/B testing, but it would be great to see some empirical evidence as well.